Cargando…
P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients
P2 purinergic receptors are overexpressed in certain cancer tissues, but the pathophysiologic relevance of purinergic signaling in hepatocellular carcinoma (HCC) remains unknown. To examine the role of P2 purinergic signaling in the pathogenesis of HCC and characterize extracellular nucleotide effec...
Autores principales: | Maynard, Janielle P., Lee, Ju-Seog, Sohn, Bo Hwa, Yu, Xiaoying, Lopez-Terrada, Dolores, Finegold, Milton J., Goss, John A., Thevananther, Sundararajah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747397/ https://www.ncbi.nlm.nih.gov/pubmed/26517690 |
Ejemplares similares
-
P2 purinergic receptor dysregulation in urologic disease
por: Maynard, Janielle P., et al.
Publicado: (2022) -
Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammation
por: Ghose, Romi, et al.
Publicado: (2004) -
Overexpression of Purinergic P2X4 Receptors in Hippocampus Rescues Memory Impairment in Rats with Type 2 Diabetes
por: Zhang, Ping-An, et al.
Publicado: (2020) -
Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2020) -
VEGF Overexpression Predicts Poor Survival in Hepatocellular Carcinoma
por: Choi, Sae Byeol, et al.
Publicado: (2017)